VistaGen Therapeutics (NasdaqCM:VTGN) FY Conference Transcript

VistaGen Therapeutics (NasdaqCM:VTGN) FY Conference March 02, 2026 03:50 PM ET Company ParticipantsShawn Singh - President and CEOConference Call ParticipantsStacy Ku - Director and Biotech AnalystStacy KuAfternoon. Welcome to TD Cowen's 46th Annual Healthcare Conference. My name is Stacy Ku. I'm one of the Biotech Analysts at TD Cowen. I'm joined by my colleague, Vishwesh Shah. With us, we have today, CEO of Vistagen, Shawn Singh. Thanks for being here today, and take it away.Shawn SinghGreat. Thanks, Stac ...